Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 232

1.

NSAID use and progression of chronic kidney disease.

Gooch K, Culleton BF, Manns BJ, Zhang J, Alfonso H, Tonelli M, Frank C, Klarenbach S, Hemmelgarn BR.

Am J Med. 2007 Mar;120(3):280.e1-7.

PMID:
17349452
2.

Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.

Moride Y, Ducruet T, Boivin JF, Moore N, Perreault S, Zhao S.

Arthritis Res Ther. 2005;7(2):R333-42. Epub 2005 Jan 17.

3.

Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.

Levin A, Djurdjev O, Beaulieu M, Er L.

Am J Kidney Dis. 2008 Oct;52(4):661-71. doi: 10.1053/j.ajkd.2008.06.023.

PMID:
18805347
4.

Natural history of CKD stage 4 and 5 patients following referral to renal management clinic.

Zhang AH, Tam P, LeBlanc D, Zhong H, Chan CT, Bargman JM, Oreopoulos DG.

Int Urol Nephrol. 2009 Dec;41(4):977-82. doi: 10.1007/s11255-009-9604-3. Epub 2009 Jul 4.

PMID:
19578968
5.

Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.

Othman M, Kawar B, El Nahas AM.

Nephron Clin Pract. 2009;113(1):c16-23. doi: 10.1159/000228071. Epub 2009 Jul 10.

PMID:
19590231
6.

Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients.

Mocroft A, Kirk O, Reiss P, De Wit S, Sedlacek D, Beniowski M, Gatell J, Phillips AN, Ledergerber B, Lundgren JD; EuroSIDA Study Group.

AIDS. 2010 Jul 17;24(11):1667-78. doi: 10.1097/QAD.0b013e328339fe53.

PMID:
20523203
7.

The unrecognized prevalence of chronic kidney disease in diabetes.

Middleton RJ, Foley RN, Hegarty J, Cheung CM, McElduff P, Gibson JM, Kalra PA, O'Donoghue DJ, New JP.

Nephrol Dial Transplant. 2006 Jan;21(1):88-92. Epub 2005 Oct 12.

8.

Predictors of the selection of coxibs over nonselective NSAIDs in an older Medicaid cohort.

Shireman TI, Rigler SK.

Am J Geriatr Pharmacother. 2006 Sep;4(3):210-8.

PMID:
17062321
9.

Estimation of glomerular filtration rate: does haemoglobin discriminate between ageing and true CKD?

Ferrari P, Xiao J, Ukich A, Irish A.

Nephrol Dial Transplant. 2009 Jun;24(6):1828-33. doi: 10.1093/ndt/gfn738. Epub 2009 Jan 8.

10.
11.

Influence of creatinine versus glomerular filtration rate on non-steroidal anti-inflammatory drug prescriptions in chronic kidney disease.

Patel K, Diamantidis C, Zhan M, Hsu VD, Walker LD, Gardner J, Weir MR, Fink JC.

Am J Nephrol. 2012;36(1):19-26. doi: 10.1159/000339439. Epub 2012 Jun 13.

12.

Channeling and prevalence of cardiovascular contraindications in users of cyclooxygenase 2 selective nonsteroidal antiinflammatory drugs.

Mosis G, Stijnen T, Castellsague J, Dieleman JP, van der Lei J, Stricker BH, Sturkenboom MC.

Arthritis Rheum. 2006 Aug 15;55(4):537-42.

13.

Risk factors for progression in patients with early-stage chronic kidney disease in the Japanese population.

Yoshida T, Takei T, Shirota S, Tsukada M, Sugiura H, Itabashi M, Ogawa T, Uchida K, Tsuchiya K, Nitta K.

Intern Med. 2008;47(21):1859-64. Epub 2008 Nov 4.

15.

Mortality risk stratification in chronic kidney disease: one size for all ages?

O'Hare AM, Bertenthal D, Covinsky KE, Landefeld CS, Sen S, Mehta K, Steinman MA, Borzecki A, Walter LC.

J Am Soc Nephrol. 2006 Mar;17(3):846-53. Epub 2006 Feb 1.

16.

Nonselective and cyclooxygenase-2-selective NSAIDs and acute kidney injury.

Winkelmayer WC, Waikar SS, Mogun H, Solomon DH.

Am J Med. 2008 Dec;121(12):1092-8. doi: 10.1016/j.amjmed.2008.06.035.

PMID:
19028206
17.

Selective cyclooxygenase-2 inhibition and cardiovascular effects: an observational study of a Medicaid population.

Shaya FT, Blume SW, Blanchette CM, Weir MR, Mullins CD.

Arch Intern Med. 2005 Jan 24;165(2):181-6.

PMID:
15668364
18.

Protective effect of chronic NSAID use on cognitive decline in older persons.

Rozzini R, Ferrucci L, Losonczy K, Havlik RJ, Guralnik JM.

J Am Geriatr Soc. 1996 Sep;44(9):1025-9.

PMID:
8790225
19.

Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study from Italy.

Minutolo R, De Nicola L, Mazzaglia G, Postorino M, Cricelli C, Mantovani LG, Conte G, Cianciaruso B.

Am J Kidney Dis. 2008 Sep;52(3):444-53. doi: 10.1053/j.ajkd.2008.03.002. Epub 2008 May 12.

PMID:
18468747
20.

COX-2 inhibitors: complex association with lower risk of hospitalization for gastrointestinal events compared to traditional NSAIDs plus proton pump inhibitors.

van der Linden MW, Gaugris S, Kuipers EJ, van Herk-Sukel MP, van den Bemt BJ, Sen SS, Herings RM.

Pharmacoepidemiol Drug Saf. 2009 Oct;18(10):880-90. doi: 10.1002/pds.1782.

PMID:
19593747
Items per page

Supplemental Content

Write to the Help Desk